“Safety of Subcutaneous Immunotherapy With Tyrosine-Adsorbed House Dust Mite Extracts in Patients With Allergic Disease”. 2017. Revista Alergia México 64 (1): 52-65. https://doi.org/10.29262/ram.v64i1.233.